Products
IP Intelligence Reports
Patexia Concierge
Patent Analyzer
Trademarks Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Login
Join
Book a Meeting
404
.
This page could not be found.
Back to All Articles
Browse articles with tag: Pharmaceutical
You must be logged in to create a new article
All Articles
Knobbe Martens
24 hours ago
•
Patent Litigation
U.S. Supreme Court Defers to Agency Decision-Making in FDA’s Denial of Premarket Approval of Flavored E-Cigarette Products
Written by:Makoto Tsunozaki, Ph.D. and Jane Dai, Ph.D. We previously reported a decision by the U.S. Food and Drug Administration...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 24, 2025
Two Bills Introduced to Target “Patent Thickets” and “Product Hopping”
Written by: Alistair J. McIntyre and Agnes Juang, Ph.D. On March 17, 2025, a bipartisan group of senators introduced two bills...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 18, 2025
•
PTAB Litigation
Limits of Inherent Anticipation in Product-By-Process Claims
Written by:Kenneth O. Aruda, Ph.D. and Nathan D. Reeves RESTEM, LLC v. JADI CELL, LLC Before Moore, Schall, and Taranto....
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 18, 2025
•
PTAB Litigation
Jepson Claim Preamble Requires Written Description Support for Conventional Aspects of the Invention
Written by:Isabella C. Pestana and Justin J. Gillett IN RE: XENCOR, INC. Before Hughes, Stark, and Schroeder (sitting by designation). ...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 13, 2025
•
Patent Litigation
District Court Finds the FDA Reasonably De-listed Eli Lilly’s Weight Loss Drug From Drug Shortage List
Written by: Rhett D. Ramsey and Robert J. Hilton, Ph.D. Congress authorized the FDA to determine whether a drug is “in...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Feb 4, 2025
Renewed Efforts in Congress for Pharmaceutical Patent Reform
Written by:Bailey R. Arenberg & Jason J. Jardine With the recent convocation of the 119th Congress, a change in administration,...
Read More
0 Likes
0 Favorites
0 Comments
<
1
2
...
33
>